Don’t Miss Out on 340B Savings from In-Office Injectables

Robert Ferraro headshot

SPONSORED CONTENT

Numerous studies have demonstrated how patient medication adherence impacts long-term outcomes and healthcare costs. 

Drug manufacturers consistently work to refine their current products, and to create new ones, in order to increase patient adherence. Medications that once needed to be administered multiple times per day, now come in extended-release versions that require only one daily dose. Manufacturers have succeeded in combining multiple drugs into single tablet regimens. This trend is evident in the evolution of HIV regimens over time. One of the first combinations of anti-retroviral therapy used to treat HIV patients required patients to take almost 20 pills per day. Now, many of the most widely used medications for managing HIV consist of only one pill, once per day.

The Next Generation

Recently, manufacturers have taken it a step further–introducing long-lasting injectable medications. Examples include Cabotegravir/rilpivirine (CABENUVA), a monthly injection to manage HIV, and long-acting buprenorphine (SUBLOCADE®), a once-a-month injection, used to help manage opioid addiction.

Read More »

340B and Value-Based Payment Keep Safety Net Doors Open

SPONSORED CONTENT

In recent years, the federal 340B drug discount program has grown in importance for safety net facilities. Covered entities are continuing to battle the effects of the COVID-19 pandemic which lead to uncertainties including provider and staffing shortages, impacts on 340B eligibility, and revenue shortfalls. The financial stability of the 340B program is paramount to the care of these hard-hit communities.

Value-based payment programs, such as Medicare accountable care organizations, can be a critical pillar supporting your 340B program. Value-based payment programs provide data on patients and prescribers that create new opportunities to capture 340B discounts. Caravan Health has been able to help clients gain an average of $200,000 per ACO participant in additional 340B revenue by optimizing their programs with accountable care data.

Covered Entities can maximize discounts in value-based payment programs

Even covered entities that are experienced with 340B are often capturing less than half of available 340B discounts. That leaves the majority of these

Read More »

Roundtable Discussion: 340B Drug Pricing Program: Recent Legislative Updates and Key Trends Impacting Hospitals, FQHCs and Other Designated Entities

SPONSORED CONTENT

The CPS 340B Solutions team is excited to host nationally recognized 340B industry thought leaders for a roundtable discussion about recent events, legislative updates, and key industry trends that impact all 340B Covered Entity designations. We hope that you will join us!

During this webinar, speakers will discuss topics including:

  • Proposed legislation
  • Updates regarding bills in the U.S. House and/or Senate
  • Contract pharmacies
  • Other 340B Program current events

A brief Q&A will occur at the end of the webinar.

Read More »

Security Matters for 340B

SPONSORED CONTENT

Over the last twelve months, more than 435 healthcare providers across the U.S. had breaches of unsecured protected health information. 73% were hacking/IT incidents with more than 27 million individuals affected. These numbers are according to the U.S. Department of Health and Human Services Office for Civil Rights Breach Portal, where HIPAA requires any breaches of over 500 individual records be reported.

HIPAA specifies a list of rules, or national standards that covered entities must follow to protect individuals’ electronic personal health information. However, HIPAA doesn’t specifically prescribe how those rules are implemented. For example, it doesn’t mandate that you use a particular encryption standard or set your passwords in a specific format. Instead, it’s up to each organization’s discretion on how to set those standards for themselves based on their unique circumstances.  There is an expectation, however, that implementations will be robust enough to provide adequate protection for personal health information.  Independent assessments by qualified

Read More »

Learn How to Sustainably Scale Your 340B Program

SPONSORED CONTENT

It’s a head-spinning Catch-22: Covered entities have never been more crucial to the well-being of community health—or more challenged to sustain their very existence. They’re dedicated to serving the most vulnerable patient communities in the United States, but constantly find themselves up against threats to the 340B program.

And yet, driven by a resolute commitment to patient care, many covered entities continue to expand their missions in the face of 340B dilemmas.

That’s why if you’re a covered entity looking to sustainably grow your 340B program in today’s ever-changing environment, I hope you’ll join me for an upcoming webinar you don’t want to miss:
Mission Possible: Future-Proofing Your 340B Program. On Tuesday, March 29th at 2 pm Eastern, we’ll be chatting with Karen Musgrove, CEO of Birmingham AIDS Outreach (BAO), about how her organization scaled its impact while continuing to offer personalized and compassionate community care. We’ll kick PowerPoint slides to the curb and instead engage in a lively discussion

Read More »

Ready to Future Proof Your Business? The Time to Act Is Now.

SPONSORED CONTENT

Drastic federal cuts to the 340B program. Alarming changes to Gilead’s Advancing Access Program. If your organization is a federal grantee or health system providing HIV care and/or prevention services, you know there has never been a more important time to future-proof your program—while still offering the highest standards of compassionate care.

What’s more, how entities provide care to their communities is quickly changing. Per CDC guidelines, providers are encouraged to prescribe PrEP to any patient who asks for it, and to have conversations about PrEP with all sexually active adolescent and adult patients. Telehealth is making care more accessible to rural communities, as well as eliminating some of the barriers and fears for patients who don’t feel comfortable in traditional health care settings.

What does all that mean for covered entities? It means the landscape is changing quickly, and there is an urgent need to consider the entire health care journey of all your patients, both those who

Read More »

View from Capitol Hill Breakfast: Get the Latest Developments in the Ever-Changing 340B Program

SPONSORED CONTENT

Are you attending the upcoming 340B Coalition Winter Conference in San Diego? Join us for breakfast!

Marriott Marquis San Diego Marina

Monday, January 31 | 8:30 a.m. PT

Omnicell 340B will be hosting a panel discussion with some of the most respected long-term experts on the 340B program at the upcoming 340B Coalition Winter Conference. Join us for a morning bite to eat and an up-to-the-minute status report on hot button topics related to the legislative, compliance, and regulatory aspects of the 340B program.

The breakfast will provide insights into:

  • What to expect for the 340B program in the new year
  • The battle over access to 340B pricing in the contract pharmacy setting
  • The latest developments on Capitol Hill and the Administration
  • How covered entities are responding and taking action to impact the program

Read More »

Visante’s Top 10 Issues Facing Hospital & Health System Pharmacy in 2022

SPONSORED CONTENT

Each year, Visante publishes its list of the top 10 issues facing hospital and health system pharmacy. In 2022, many challenges derive from the pandemic but also present opportunities for leaders to implement new solutions that will drive stronger performance in the future.

  1. The Pandemic

With a second pandemic winter to deal with, many of the country’s hospitals and other 340B providers need help. Overall, 80+% of hospitals are still struggling with being short-staffed and backlogged from the last wave of COVID-19 as well as challenged financially with increased expenses and decreased revenue. Health centers and other 340B providers have faced many of the same challenges and have played a crucial role in treating our most vulnerable patient populations during this unprecedented time. 340B covered entities are now looking at colder months with a potentially bad influenza season creating a possible “twindemic” situation. Hospitals and other 340B covered entities are looking at a possible “perfect storm” of high demand,

Read More »

A Personal Look at Some of the Nation’s Top 340B Lawyers

SPONSORED CONTENT

Do you think you know Powers Law?  You may know that Powers has represented 340B safety net hospitals, Ryan White clinics, community health centers as well as state and local governments and retail pharmacies since the 340B program’s inception in 1992.  You may also know that Powers has a strong reputation for compliance work, 340B-related litigation, and building coalitions to advocate effectively for the 340B program.  What you don’t know about us may surprise you.

Bill von Oehsen, JD

  • Bill played a key role in helping to enact the 340B program in 1992, as well as to expand the law in 2010 under the Affordable Care Act to include additional safety net hospitals as covered entities and to establish numerous program integrity requirements.
  • Bill helped to establish 340B Health, an advocacy organization of more than 1,400 public and private nonprofit hospitals participating in the 340B program. He also helped organize the 340B Coalition, an organization of a dozen national associations
Read More »

A Q&A with Two 340B Industry Experts About the Importance of Innovation and a Competitive Edge

SPONSORED CONTENT

The word “innovation” gets tossed around so much these days that we almost forget its meaning—the introduction of new and different ideas for out-of-the-box problem solving that have meaningful impacts. Yet, innovation is different in every industry, and it’s essential in a field as complex as 340B.

To get a handle on it, we sat down with healthcare technology veteran Andrew Stevenson, VP of Product Strategy and Business Development, and 340B industry expert Christy Bryant, VP, Customer Service & Regulatory Affairs at Macro Helix, a third-party administrator that facilitates the 340B programs of more than 900 covered entities as well as hospital-owned and retail pharmacies. Responsible for supporting customer relationships, and driving the execution of critical innovation programs with Macro Helix’s customers, they have valuable insights to share for a 340B community faced with new challenges almost daily.

In a nutshell, what is Macro Helix? How do you help customers succeed with 340B?

Christy Bryant: We help healthcare entities maximize their 340B

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live